Clinical trial NCT06330142: Hippotherapy Teenager-pediatric Radiotherapy
Official title: T-QAP: radioTherapy eQuicie Adolescent - Pediatrics
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Radiotherapy
Keywords: Radiotherapy
Equicie
Adolescent
Pediatric
Lead sponsor: Institut de cancérologie Strasbourg Europe
Sponsor class: OTHER
First posted: 2024-03-26
Enrollment: 22
Sex: ALL
Minimum age (years): 8
Maximum age (years): 17
Standard ages: CHILD
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Brief summary: This study proposes a horse-assisted therapy (HAT) approach to accompany children and young adults undergoing irradiation in the ICANS Radiotherapy Department.

The aim of this new approach is to improve quality of life and reduce anxiety in children and adolescents treated with radiotherapy. The impact of equine-assisted therapy on quality of life and anxiety disorders will be described prospectively between the start and end of irradiation in children and parents who agree to inclusion.

Detailed description: Electro-radiology medical technician (ERMT) are privileged contacts with children. They accompany them every day during radiotherapy sessions. An animal-mediated approach would provide a new out-of-hospital environment. The equine sessions, precious moments when the child can forget about his illness, would enable him to escape from his condition as a patient. Indeed, the sick child adopts a posture to withstand treatment and take on responsibilities such as "not crying" and "being brave". These moments, away from the hospital, are essential to the smooth running of care, since they limit the weariness induced by daily radiotherapy sessions and help preserve the quality of caregiver/child cooperation during treatment.

Eligibility criteria: Inclusion Criteria:

* Children aged 8 to \<18 years.
* With an indication for radiotherapy for cancer (of any type)
* Patients hospitalized and/or managed on an ambulatory basis
* WHO ≤ 2
* Child and parents (or accompanying adults) who speak and understand French
* Free, express and informed consent of the adult patient OR of those exercising parental authority for minor patients
* Child with social security coverage

Exclusion Criteria:

* Children afraid of horses and stables
* Contraindication to the practice of equine-assisted therapy (allergy to horses or dust, children with asthma attacks triggered by dust/animal hair ...)
* Patient on stretcher
* Children or parents (or carers) with significant cognitive impairment, making self-assessment or hetero-assessment impossible even with assistance
* Unavailability or lack of interest in participating in equine-assisted therapy sessions

Primary outcomes:
measure: Evolution of quality of life between the beginning and the end of horse-assisted therapy (HAT) in children (self-questionnaire) treated with radiotherapy
timeFrame: before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions
Secondary outcomes:
measure: Improving children's quality of life between the start and end of irradiation (hetero-questionnaire) by HAT
timeFrame: before radiotherapy, halfway through the HAT sessions (at 5 weeks), at the end of the HAT sessions (at 10 weeks) and one month after the end of the HAT sessions
measure: Decrease anxiety disorders between the beginning - child version and end of irradiation in children (self-questionnaire) with HAT
timeFrame: before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions
measure: Decrease anxiety disorders between the beginning - parents' version and end of irradiation in children (self-questionnaire) with HAT
timeFrame: before radiotherapy, halfway through HAT sessions (at 5 weeks), at the end of HAT sessions (at 10 weeks) and one month after the end of HAT sessions
measure: Assessing the acute side effects of radiotherapy at the start and end of irradiation
timeFrame: at the start and end of radiotherapy sessions (from 3 to 7 weeks)
measure: Study the relevance of the various equestrian activities proposed as a strategy for improving care through the horse
timeFrame: At every HAT sessions (up to 10 weeks)
measure: Evaluate participant's expectations and satisfaction with their care
timeFrame: at the beginning and end of HAT sessions (up to 10 weeks)
measure: Assess the medical electroradiology technician's (MERT's) impression of the child's well-being during irradiation
timeFrame: every week during radiotherapy (from 3 to 7 weeks)
measure: Assessing the impact of HAT on the child during irradiation according to the MERT
timeFrame: at each radiotherapy session (from 3 to 7 weeks)
measure: Evaluate the rider's impression of the child's well-being of the child during HAT sessions
timeFrame: at the end of the first session and at the end of the last session of HAT (up to 10 weeks)
measure: Assessing the impact of an alternative activity on parents' satisfaction with care
timeFrame: at the end of the HAT sessions (at 10 weeks)
Other outcomes:
Locations:
city: Strasbourg
country: France
facility: Institut de Cancerologie Strasbourg Europe
Study officials:
References: